RankingsPricing
  1. JP-listed companies
  2. KISSEI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Net income

KISSEI PHARMACEUTICAL CO.,LTD.【JP:4547】

Market cap
¥229B
P/E ratio
15.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Mar 31, 202511,975+6.08%
Mar 31, 202411,289+6.16%
Mar 31, 202310,634-18.40%
Mar 31, 202213,032+142.32%
Mar 31, 20215,378+86.22%
Mar 31, 20202,888-47.82%
Mar 31, 20195,535-39.16%
Mar 31, 20189,098+17.17%
Mar 31, 20177,765-5.25%
Mar 31, 20168,195+14.01%
Mar 31, 20157,188-17.65%
Mar 31, 20148,729+85.64%
Mar 31, 20134,702+2.37%
Mar 31, 20124,593

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)